Group 1 - The Fundstrat Granny Shots US Large Cap ETF (GRNY) launched in November 2024, includes stocks based on short and long-term trends identified by Fundstrat [1][7] - GRNY ETF has eight stocks in common with the Dow Jones Industrial Average (DIA), indicating alignment with certain investment themes [2][6] - The current themes for the GRNY ETF include PMI recovery, energy stocks, cybersecurity stocks, labor suppliers, targeting millennials, and easing financial conditions [7] Group 2 - The eight common stocks between GRNY and DIA include Caterpillar Inc, Goldman Sachs Group Inc, Apple Inc, JPMorgan Chase & Co., NVIDIA Corp, American Express Co, Amazon.com Inc, and Microsoft Corp [3][4][5][6] - GRNY is down 0.32% year-to-date but has increased by 18.31% over the past 52 weeks, while DIA is up 3.46% year-to-date and 12.08% over the past 52 weeks [7][9] - The Dow Jones Industrial Average consists of 30 stocks across various sectors, representing a broad view of the overall stock market health [8]

Group 1 - The analyst has over a decade of experience researching various companies across different sectors, including commodities like oil, natural gas, gold, and copper, as well as technology firms such as Google and Nokia [1] - The analyst has transitioned from writing a blog to creating a value investing-focused YouTube channel, where extensive research on hundreds of companies has been conducted [1] - The analyst expresses a particular interest in covering metals and mining stocks, while also being comfortable with other industries like consumer discretionary/staples, REITs, and utilities [1]

Core Viewpoint - Investors are evaluating Allison Transmission (ALSN) and Modine (MOD) for potential undervalued stock opportunities in the Automotive - Original Equipment sector [1] Valuation Metrics - ALSN has a forward P/E ratio of 12.03, while MOD has a significantly higher forward P/E of 45.63 [5] - ALSN's PEG ratio is 1.21, indicating a more favorable valuation compared to MOD's PEG ratio of 1.34 [5] - ALSN's P/B ratio stands at 5.26, compared to MOD's P/B ratio of 10.24, suggesting ALSN is more undervalued relative to its book value [6] Earnings Outlook - Both ALSN and MOD have a Zacks Rank of 1 (Strong Buy), indicating positive earnings estimate revisions and improving earnings outlooks [3] - Despite both companies having solid earnings prospects, ALSN is identified as the superior value option based on valuation metrics [7] Value Grades - ALSN holds a Value grade of A, while MOD has a Value grade of D, highlighting ALSN's stronger position in terms of value [6]

Core Viewpoint - The article compares The Charles Schwab Corporation (SCHW) and Robinhood Markets, Inc. (HOOD) to determine which stock is more attractive to value investors [1] Group 1: Zacks Rank and Earnings Outlook - SCHW has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while HOOD has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank system emphasizes companies with positive earnings estimate revisions, suggesting that SCHW is likely experiencing a more favorable earnings outlook than HOOD [3] Group 2: Valuation Metrics - SCHW has a forward P/E ratio of 16.54, significantly lower than HOOD's forward P/E of 31.41, indicating that SCHW may be undervalued [5] - SCHW's PEG ratio is 0.77, while HOOD's PEG ratio is 1.21, suggesting that SCHW offers better value relative to its expected earnings growth [5] - SCHW's P/B ratio is 4.07 compared to HOOD's P/B of 7.66, further indicating that SCHW is more attractively valued [6] - Based on these metrics, SCHW earns a Value grade of B, while HOOD receives a Value grade of D, making SCHW the preferred choice for value investors [6]

Core Viewpoint - Investors in the Medical - Biomedical and Genetics sector should consider Exelixis (EXEL) and Liquidia Corporation (LQDA) for potential value opportunities [1] Group 1: Company Rankings - Exelixis has a Zacks Rank of 1 (Strong Buy), while Liquidia Corporation has a Zacks Rank of 2 (Buy) [3] - EXEL has likely seen a stronger improvement in its earnings outlook compared to LQDA [3] Group 2: Valuation Metrics - EXEL has a forward P/E ratio of 12.65, whereas LQDA has a significantly higher forward P/E of 62.04 [5] - EXEL's PEG ratio is 0.65, indicating better value relative to its expected earnings growth compared to LQDA's PEG ratio of 1.13 [5] - EXEL's P/B ratio is 5.33, in contrast to LQDA's P/B ratio of 158.47, suggesting a more favorable valuation for EXEL [6] Group 3: Value Grades - Based on various valuation metrics, EXEL holds a Value grade of B, while LQDA has a Value grade of D [6] - EXEL stands out in both Zacks Rank and Style Scores models, making it a more attractive option for value investors [6]

Core Viewpoint - The comparison between Merit Medical (MMSI) and Straumann Holding AG (SAUHY) indicates that MMSI is currently viewed as the better option for investors seeking undervalued stocks due to its stronger earnings estimate revisions and favorable valuation metrics [1][3]. Group 1: Zacks Rank and Earnings Estimates - MMSI has a Zacks Rank of 2 (Buy), while SAUHY has a Zacks Rank of 3 (Hold), suggesting that MMSI's earnings estimate revision activity is more favorable [3]. - The Zacks Rank system emphasizes stocks with strong earnings estimate revision trends, which is a positive indicator for MMSI [2]. Group 2: Valuation Metrics - MMSI has a forward P/E ratio of 20.07, compared to SAUHY's forward P/E of 28.57, indicating that MMSI may be undervalued relative to SAUHY [5]. - The PEG ratio for MMSI is 1.95, while SAUHY's PEG ratio is 2.78, further supporting the notion that MMSI offers better value based on expected EPS growth [5]. - MMSI's P/B ratio stands at 3.15, significantly lower than SAUHY's P/B of 8.14, reinforcing the argument for MMSI being the more attractive investment option [6]. Group 3: Value Grades - Based on various valuation metrics, MMSI holds a Value grade of B, while SAUHY has a Value grade of C, indicating that MMSI is perceived as a better value investment [6].

Core Viewpoint - Investors interested in mining and gold stocks should consider Iamgold (IAG) as a potentially undervalued option compared to Triple Flag Precious Metals (TFPM) [1] Valuation Metrics - IAG has a Zacks Rank of 2 (Buy), indicating stronger earnings estimate revision activity compared to TFPM, which has a Zacks Rank of 3 (Hold) [3] - IAG's forward P/E ratio is 10.38, significantly lower than TFPM's forward P/E of 27.86, suggesting IAG may be undervalued [5] - IAG has a PEG ratio of 0.26, while TFPM's PEG ratio is 1.00, indicating IAG's expected earnings growth is more favorable [5] - IAG's P/B ratio is 3.61, compared to TFPM's P/B of 3.89, further supporting IAG's valuation attractiveness [6] Value Grades - Based on various valuation metrics, IAG holds a Value grade of B, while TFPM has a Value grade of D, indicating IAG is currently the superior option for value investors [6][7]

Core Viewpoint - Investors in the Banks - Southwest sector should consider Texas Capital (TCBI) and Cullen/Frost Bankers (CFR) for potential value opportunities [1] Group 1: Zacks Rank and Earnings Outlook - Texas Capital has a Zacks Rank of 1 (Strong Buy), while Cullen/Frost Bankers has a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook for TCBI [3] - The Zacks Rank system emphasizes companies with positive earnings estimate revisions, suggesting TCBI is likely experiencing a more favorable earnings outlook [3] Group 2: Valuation Metrics - TCBI has a forward P/E ratio of 13.53, compared to CFR's forward P/E of 14.37, indicating TCBI may be undervalued [5] - TCBI's PEG ratio is 0.50, while CFR's PEG ratio is significantly higher at 5.38, suggesting TCBI offers better value relative to its expected earnings growth [5] - TCBI's P/B ratio is 1.41, compared to CFR's P/B of 2.11, further supporting TCBI's valuation attractiveness [6] Group 3: Value Grades - TCBI has earned a Value grade of B, while CFR has a Value grade of C, indicating TCBI is viewed more favorably by value investors [6] - Stronger estimate revision activity and more attractive valuation metrics position TCBI as the superior option for value investors [7]

Core Viewpoint - The article emphasizes the importance of identifying value investment opportunities in Asia, particularly focusing on stocks with significant discrepancies between market price and intrinsic value, as well as companies with strong competitive advantages [1] Group 1: Investment Strategy - The research service targets value investors looking for Asia-listed stocks that are undervalued, specifically deep value balance sheet bargains and wide moat stocks [1] - Deep value balance sheet bargains include assets purchased at a discount, such as net cash stocks, net-nets, and low price-to-book (P/B) ratio stocks [1] - Wide moat stocks refer to high-quality businesses with sustainable competitive advantages, including "Magic Formula" stocks and hidden champions [1] Group 2: Market Focus - The primary focus is on the Hong Kong market, where the analyst has over a decade of experience in both buy and sell-side roles [1] - The investment group provides monthly updates and watch lists to assist investors in identifying potential opportunities [1]

Core Insights - The article emphasizes the importance of the Zacks Rank system, which focuses on earnings estimates and revisions to identify strong stocks [1] - Value investing is highlighted as a popular and successful strategy across various market conditions, relying on key valuation metrics to find undervalued stocks [2] Company Analysis - Brennt (BNTGY) is identified as a notable stock for value investors, currently holding a Zacks Rank of 2 (Buy) and a Value grade of A [4] - BNTGY has a P/E ratio of 13.92, significantly lower than the industry average P/E of 23.14, indicating potential undervaluation [4] - The stock's Forward P/E has fluctuated between a high of 15.62 and a low of 11.03 over the past year, with a median of 13.13 [4] - The P/S ratio for BNTGY is 0.58, compared to the industry average P/S of 0.74, further supporting the notion of undervaluation [5] - Overall, BNTGY is positioned as one of the market's strongest value stocks, bolstered by a favorable earnings outlook [6]